Publicaciones en colaboración con investigadoras/es de University of Toronto (31)

2024

  1. A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity

    Neurobiology of Disease, Vol. 194

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo

    Science translational medicine, Vol. 15, Núm. 697, pp. eadf4549

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Health financing policies during the COVID-19 pandemic and implications for universal health care: a case study of 15 countries

    The Lancet Global Health, Vol. 11, Núm. 12, pp. e1964-e1977

  4. Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses

    Cell Reports, Vol. 42, Núm. 4

  5. Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies

    Autophagy, Vol. 19, Núm. 2, pp. 660-677

2022

  1. Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 7

  2. Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 4

2021

  1. Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile

    iScience, Vol. 24, Núm. 9

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice

    Science Advances, Vol. 7, Núm. 49

  4. Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease

    Scientific Reports, Vol. 11, Núm. 1

  5. Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane Environments

    Cell Reports, Vol. 32, Núm. 7

  2. Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

    Nature Communications, Vol. 11, Núm. 1

  3. Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies

    Nature Communications, Vol. 11, Núm. 1

2019

  1. 3D Bioprinting in Skeletal Muscle Tissue Engineering

    Small, Vol. 15, Núm. 24

  2. Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation

    Molecular Psychiatry, Vol. 23, Núm. 6, pp. 1530-1540